Evidence map›Paper›PMID 42375913›Full record

ReviewCureus2026

Acute Kidney Injury in the Intensive Care Unit: Recent Advances.

Ibrahim Fadl Mahmoud, Saud M Erwi, Ali M Alfageeh

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ibrahim Fadl MahmoudAnesthesia, Intensive Care and Pain Management, Damietta Faculty of Medicine, Al-Azhar University, New Damietta, EGY.
Saud M ErwiCritical Care Unit, Armed Forces Hospital Jazan, Jazan, SAU.
Ali M AlfageehNephrology and Kidney Transplant Center, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) in the intensive care unit (ICU) is a heterogeneous syndrome characterized by kidney stress, structural injury, functional decline, requirement for extracorporeal organ support, and incomplete recovery, rather than a single creatinine-defined event. Current critical care practice increasingly integrates conventional Kidney Disease: Improving Global Outcomes (KDIGO) diagnostic criteria with urine output trajectories, cystatin C measurement when serum creatinine is unreliable, structural damage biomarkers when results will change management, hemodynamic phenotyping, venous congestion assessment, nephrotoxin stewardship, fluid stewardship, and recovery planning. This narrative review summarizes recent advances relevant to adult ICU care, including evolving definitions of AKI and acute kidney disease, sepsis-associated microcirculatory and cellular injury, systemic venous congestion, point-of-care ultrasound-assisted congestion assessment, biomarker-triggered prevention bundles, individualized renal replacement therapy (RRT), continuous renal replacement therapy (CRRT), and post-ICU recovery pathways. Key recommendations include avoiding automatic fluid loading in response to oliguria; interpreting mean arterial pressure together with cardiac output, central venous pressure, right ventricular function, and intra-abdominal pressure; using biomarkers only within an actionable response pathway; and initiating RRT according to urgent or trajectory-based indications rather than serum creatinine alone. Precision ICU nephrology is best conceptualized as the timely alignment of phenotype, risk, trajectory, and organ support objectives.

Indexed as

acute kidney injurybiomarkerscritical care nephrologyfluid stewardshipintensive care unitrenal replacement therapyvenous congestion

Identifiers

PMID42375913
PMCPMC13311353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.